# Tesorai

> Cloud proteomics platform that reprocesses raw mass-spectrometry data and compares results with curated research datasets.

## Why it is interesting

Its $5.3M November 18 seed brings funding to $8M; researchers can revisit raw experiments rather than rely only on published paper conclusions. A claimed Alzheimer's biomarker rediscovery is a preprint finding, not a diagnostic validation.

## Profile

- **Latest funding:** Seed — $5.3M (November 18, 2026)
- **Latest known valuation:** Not publicly disclosed
- **Total disclosed equity funding:** $5.3M
- **Stage:** seed
- **Status:** private
- **Industries:** N/A
- **Coverage:** full
- **Last updated:** 2026-11-19
- **Latest funding investors:** Perplexity Fund, IQT, South Central Ventures, New Stack Ventures, NextGen Venture Partners, f7 Ventures, VitalStage Ventures, ZAKA

## Key facts

- $5.3M seed announced November 18, 2026; cumulative $8M, investors named but no issuer-confirmed lead.
- Search / Trove / Chat support mass-spectrometry reanalysis and cross-study replication.
- The reported p-tau217 rediscovery derives from an August company preprint; independent biomarker validation remains necessary.

## Funding history

- Seed · $5.3M · November 18, 2026
  Source: https://www.prnewswire.com/news-releases/tesorai-raises-5-3-million-to-put-vast-troves-of-untapped-research-data-to-work-302944021.html

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** November 19, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/tesorai-ai-proteomics
